Intercept Pharma says possible Ocaliva boxed warning will not be restrictive

(Reuters) – Intercept Pharmaceuticals Inc said on Monday an update to the label of its liver drug, Ocaliva, could include a boxed warning to help ensure proper dosing of patients, but added that it did not expect the change to be restrictive.

Source: Reuters Health News